Medical Oncologist
Palbociclib monitoring
Tests and Monitoring — While You Are on Palbociclib
Palbociclib requires regular blood tests throughout treatment. These tests directly decide whether your next cycle goes ahead, is delayed, or needs adjustment — they are not optional.
Medically reviewed by Dr. Bharati Devi Gorantla, Medical Oncologist, MBBS · MD · DM (Adyar, Chennai) · ECMO · MRCP SCE (UK) · Last reviewed August 2026
- Tests before every cycle — A blood count is required before each new cycle can begin.
- Extra checks in the first two cycles — Mid-cycle tests are added in Cycles 1 and 2 when the risk of a low count is highest.
- Liver function is also watched — Palbociclib can affect liver enzymes, so these are checked alongside your blood count.
- A low count can pause your dose — If your neutrophils are too low, your team will delay the next cycle until they recover.
17+
Cancer Specialists
on Panel
on Panel
96.9%
Breast Cancer
Survival Rate*
Survival Rate*
15,000+
Patients
Treated
Treated
4.8★
Google Rating
(800+ reviews)
(800+ reviews)
Palbociclib requires a complete blood count before you start, at mid-cycle during the first two cycles, and before every subsequent cycle. These tests check your neutrophil count. A low result may delay or adjust your dose. NCCN and ASCO guidelines treat this schedule as mandatory, not optional.
What is the monitoring schedule for palbociclib?
Before your first dose
Your team orders a complete blood count (CBC) with differential and liver function tests (LFTs) before treatment begins. These are your baseline — the numbers all future results will be compared against.
Day 15 of Cycle 1
A CBC is repeated at the midpoint of your first cycle. The risk of a neutrophil drop is highest early in treatment, so this mid-cycle check is built into the standard schedule. It is usually a blood draw at a collection centre — you do not need to be admitted.
Day 15 of Cycle 2
The mid-cycle blood test is repeated during your second cycle. After this, if your counts have been stable, mid-cycle checks are generally no longer required.
Before each subsequent cycle
From Cycle 3 onwards, a CBC is done at the start of every new cycle before your next course of tablets begins. Your team will not clear the next cycle until they have seen the result.
Periodic liver function tests
LFTs are repeated at intervals throughout treatment. How often depends on your individual results and your team's protocol. You will be told if anything needs closer follow-up.
What to do before each blood test appointment
- Bring a list of all medicines, supplements, and herbal preparations — including anything bought without a prescription.
- Tell the team if you have had a fever, chills, unusual tiredness, or mouth sores since your last visit.
- Tell the team if you have started any new medicine, including those prescribed by another doctor.
- Do not skip the blood test even if you feel well — a low count rarely causes symptoms you would notice.
- Ask when and how you will receive your result, so you are not left waiting without a clear timeline.
Meet the Specialists
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Surgical Oncologist
Surgical Oncologist
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Surgical Oncologist
Radiation Oncologist
Radiation Oncologist
Radiation Oncologist
Hematologist
Interventional Radiologist
Dr. Mohammed Imran
Surgical Oncologist
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Get a straight answer from a specialist
45 minutes, your reports reviewed, your questions answered in plain language.
What does each test result tell your team?
The CBC measures the number and type of cells in your blood. The result your oncologist watches most closely is the neutrophil count, because palbociclib can reduce it significantly.
Neutrophils are the white blood cells that protect you from bacterial infection. A low count, called neutropenia, does not cause symptoms you would notice on your own — which is exactly why the blood test cannot be replaced by how you feel.
Liver function tests measure enzymes that show whether your liver is processing the drug normally. Elevated results may lead to a closer monitoring schedule or a dose adjustment.
If results are within the range your team expects, your next cycle proceeds. If they are not, your team will explain what the next step is before you leave.
What happens if your neutrophil count is low?
A low count at the start of a cycle usually means your next course of tablets is paused for around one week while your counts recover. This is a planned pause, not a sign that treatment has failed.
If counts remain low after that week, your oncologist may reduce the dose. NCCN guidance describes dose reduction as a standard management step in this situation, not a last resort.
Febrile neutropenia — a fever that develops when your neutrophil count is already low — is a medical emergency. If you develop a temperature alongside any sign of infection during treatment, go to the emergency department the same day. Do not wait for your next scheduled appointment.
Did you know?
Neutropenia is the most common reason for a dose pause on palbociclib, but most people who need a delay or reduction are able to continue treatment at an adjusted level.
The monitoring schedule exists so that adjustments can be made before a low count becomes a serious problem — catching it early is what keeps treatment on track.
Source: NCCN Clinical Practice Guidelines in Oncology — Breast Cancer
Explore 75 more Breast Cancer Targeted Medicines topics
Drug Deep Dive: Palbociclib (Ibrance)
- Diet and Nutrition While on Palbociclib
- Drug, Food and Supplement Interactions With Palbociclib
- Fatigue on Palbociclib: Why It Happens and What Genuinely Helps
- Fertility, Pregnancy and Contraception on Palbociclib
- How Does Palbociclib Work? The CDK4/6 Inhibitor Explained
- How Long Does Palbociclib Take to Work?
- How Long Will You Stay on Palbociclib?
- Low White Cell Count on Palbociclib: Expected, and Rarely Dangerous
- Mouth Sores and Infection Risk on Palbociclib
- Palbociclib (Ibrance, Palbace): The Complete Patient Guide
- Palbociclib Myths: Low Counts, Hair Loss and Stopping Early
- Palbociclib Price in India: Brand, Generic and Monthly Cost
- Palbociclib Side Effects: The Complete List and Timeline
- Palbociclib Success Rate and Survival: An Honest Look at the Numbers
- Palbociclib With Letrozole or Fulvestrant: Understanding Your Combination
- Palbociclib in Early Breast Cancer: Why It Is Not Given After Surgery
- Palbociclib in Elderly Patients and Those With Other Illnesses
- Palbociclib vs Ribociclib vs Abemaciclib: Which CDK4/6 Inhibitor?
- Taking Palbociclib: Food, Timing and What to Do If You Miss a Dose
- Tests and Monitoring While You Are on Palbociclib
- The 21-Days-On, 7-Days-Off Palbociclib Cycle Explained
- When Palbociclib Stops Working: Resistance and What Comes Next
- Who Is Eligible for Palbociclib? Hormone-Receptor-Positive, HER2-Negative Breast Cancer
- Will Insurance or a Government Scheme Pay for Palbociclib?
- Work, Travel and Daily Life on Palbociclib
Drug Deep Dive: Trastuzumab (Herceptin)
- Adjuvant Trastuzumab: Why Exactly 12 Months After Surgery?
- Diet and Nutrition While on Trastuzumab
- Drug, Food and Supplement Interactions With Trastuzumab
- Fatigue, Chills and Flu-Like Symptoms After a Trastuzumab Infusion
- Fertility, Pregnancy and Contraception on Trastuzumab
- Heart Function and Trastuzumab: Understanding Your ECHO Reports
- Herceptin vs Biosimilar Trastuzumab: Are They Really the Same?
- How Does Trastuzumab Work? The Anti-HER2 Monoclonal Antibody Explained
- How Long Does Trastuzumab Take to Work?
- How Long Will You Stay on Trastuzumab?
- Subcutaneous Trastuzumab vs IV Infusion: Which Suits You Better?
- Tests and Monitoring While You Are on Trastuzumab
- Trastuzumab (Herceptin and biosimilars): The Complete Patient Guide
- Trastuzumab Infusion Day: Premedication, Duration and What to Expect
- Trastuzumab Infusion Reactions: What Happens and How They're Managed
- Trastuzumab Myths: 'It's Chemotherapy' and Other Misunderstandings
- Trastuzumab Price in India: Innovator, Biosimilar and Cost Per Cycle
- Trastuzumab Side Effects: The Complete List and Timeline
- Trastuzumab Success Rate and Survival: An Honest Look at the Numbers
- Trastuzumab With Pertuzumab, Chemotherapy and Hormone Therapy
- Trastuzumab in Elderly Patients and Those With Other Illnesses
- When Trastuzumab Stops Working: Resistance and What Comes Next
- Who Is Eligible for Trastuzumab? HER2-Positive Breast and Gastric Cancer
- Will Insurance or a Government Scheme Pay for Trastuzumab?
- Work, Travel and Daily Life on Trastuzumab
Drug Deep Dive: Trastuzumab Deruxtecan (Enhertu)
- Diet and Nutrition While on Trastuzumab Deruxtecan
- Drug, Food and Supplement Interactions With Trastuzumab Deruxtecan
- Enhertu Myths: 'It's Just Stronger Herceptin' and Cost Misconceptions
- Enhertu in Breast, Gastric and Lung Cancer: One Drug, Three Diseases
- Fertility, Pregnancy and Contraception on Trastuzumab Deruxtecan
- HER2-Low Breast Cancer: How Enhertu Created an Entirely New Patient Group
- How Does Trastuzumab Deruxtecan Work? The HER2-Directed Antibody-Drug Conjugate Explained
- How Long Does Trastuzumab Deruxtecan Take to Work?
- How Long Will You Stay on Trastuzumab Deruxtecan?
- Interstitial Lung Disease on Enhertu: The Side Effect That Needs Immediate Action
- Low Blood Counts, Hair Loss and Heart Monitoring on Enhertu
- Nausea and Vomiting on Trastuzumab Deruxtecan: Managing a High-Risk ADC
- Tests and Monitoring While You Are on Trastuzumab Deruxtecan
- Trastuzumab Deruxtecan (Enhertu): The Complete Patient Guide
- Trastuzumab Deruxtecan Infusion Day: Premedication, Duration and What to Expect
- Trastuzumab Deruxtecan Price in India: Innovator, Biosimilar and Cost Per Cycle
- Trastuzumab Deruxtecan Side Effects: The Complete List and Timeline
- Trastuzumab Deruxtecan Success Rate and Survival: An Honest Look at the Numbers
- Trastuzumab Deruxtecan in Elderly Patients and Those With Other Illnesses
- Trastuzumab Deruxtecan vs T-DM1 and Trastuzumab: How ADCs Differ
- When Trastuzumab Deruxtecan Stops Working: Resistance and What Comes Next
- Where Trastuzumab Deruxtecan Fits Alongside Chemotherapy and Hormone Therapy
- Who Is Eligible for Trastuzumab Deruxtecan? HER2-Positive and HER2-Low Breast, Gastric and Lung Cancer
- Will Insurance or a Government Scheme Pay for Trastuzumab Deruxtecan?
- Work, Travel and Daily Life on Trastuzumab Deruxtecan
Next step
Still not sure what applies to you?
Send your reports across and a senior medical oncologist will go through what they mean, what is known, and what the options actually are.
Common questions
Frequently asked questions
Can I start my next cycle of palbociclib tablets before my blood result is back?
No. Your team must review the result before your next cycle begins. If the result is not available, they cannot confirm it is safe to proceed. Contact your team as soon as possible if your test is delayed rather than starting tablets and assuming everything is fine.
How will I know if my neutrophil count is too low?
You will not know from symptoms alone — neutropenia is usually silent until it becomes severe. This is why the scheduled blood tests exist. Your team will contact you with the result and tell you whether to start your next cycle, wait, or come in. Do not begin the next cycle until you have heard from them.
What signs of infection should I watch for between tests?
A fever is the main sign to act on urgently. If you develop a temperature, chills, or feel suddenly unwell between tests, contact your oncology team the same day — or go to the emergency department if you cannot reach them. Other signs to report include pain when passing urine, a worsening cough, or unusual redness and warmth around any wound. Do not manage a fever with paracetamol alone and wait to see if it settles.
Can my blood be drawn at any collection centre, or must it be done at CION?
Your team will tell you where to go. In many cases a local collection centre is fine, provided the result reaches your oncologist before your next cycle is due. Confirm the arrangement with your team so there is no gap between the test and the decision on whether your cycle can start.
Does the monitoring schedule change after I have been on palbociclib for a long time?
The pre-cycle CBC continues throughout treatment — it does not stop after the early cycles. What may change is how often your team orders liver function tests or other checks, based on how your individual results have looked. Any change to your schedule will be explained to you. If you are unsure what is currently planned, ask at your next visit.